{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:26:52Z","timestamp":1785929212376,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12022-021-09671-4","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T21:02:40Z","timestamp":1614805360000},"page":"415-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Pangenomic Classification of Pituitary Neuroendocrine Tumors: Quality Histopathology is Required for Accurate Translational Research"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"issue":"1","key":"9671_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R et al. Pangenomic Classification of Pituitary Neuroendocrine Tumors. Cancer Cell 2020; 37(1):123-134.","journal-title":"Cancer Cell"},{"key":"9671_CR2","first-page":"798","volume":"19","author":"SL Asa","year":"1998","unstructured":"Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998; 19:798-827.","journal-title":"Endocr Rev"},{"issue":"6","key":"9671_CR3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","volume":"31","author":"O Mete","year":"2018","unstructured":"Mete O, Cintosun A, Pressman I, Asa SL. Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod Pathol 2018; 31(6):900-909.","journal-title":"Mod Pathol"},{"issue":"4","key":"9671_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12022-020-09646-x","volume":"31","author":"O Mete","year":"2020","unstructured":"Mete O, Asa SL. Structure, Function, and Morphology in the Classification of Pituitary Neuroendocrine Tumors: the Importance of Routine Analysis of Pituitary Transcription Factors. Endocr Pathol 2020; 31(4):330-336.","journal-title":"Endocr Pathol"},{"issue":"4","key":"9671_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","volume":"32","author":"O Mete","year":"2019","unstructured":"Mete O, Kefeli M, Caliskan S, Asa SL. GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 2019; 32(4):484-489.","journal-title":"Mod Pathol"},{"issue":"4","key":"9671_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O et al. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas. Endocr Pathol 2015; 26(4):349-355.","journal-title":"Endocr Pathol"},{"key":"9671_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.humpath.2020.10.004","volume":"107","author":"SL Asa","year":"2021","unstructured":"Asa SL, Mete O. Cytokeratin profiles in pituitary neuroendocrine tumors. Hum Pathol 2021; 107:87-95.","journal-title":"Hum Pathol"},{"key":"9671_CR8","first-page":"1275","volume":"77","author":"SL Asa","year":"1993","unstructured":"Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP. Cell type-specific expression of the pituitary transcription activator Pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1993; 77:1275-1280.","journal-title":"J Clin Endocrinol Metab"},{"key":"9671_CR9","first-page":"2165","volume":"81","author":"SL Asa","year":"1996","unstructured":"Asa SL, Bamberger A-M, Cao B, Wong M, Parker KL, Ezzat S. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 1996; 81:2165-2170.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9671_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12022-018-9545-4","volume":"29","author":"O Mete","year":"2018","unstructured":"Mete O, Alshaikh OM, Cintosun A, Ezzat S, Asa SL. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages. Endocr Pathol 2018; 29(4):332-338.","journal-title":"Endocr Pathol"},{"key":"9671_CR11","first-page":"17","volume-title":"Endocrine Pathology Update","author":"K Kovacs","year":"1990","unstructured":"Kovacs K, Asa SL, Horvath E et al. Null cell adenomas of the pituitary: Attempts to resolve their cytogenesis. In: Lechago J, Kameya T, editors. Endocrine Pathology Update. New York: Field and Wood, 1990: 17-31."},{"key":"9671_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF00783026","volume":"413","author":"S Yamada","year":"1988","unstructured":"Yamada S, Asa SL, Kovacs K. Oncocytomas and null cell adenomas of the human pituitary: morphometric and in vitro functional comparison. Virchows Arch [A] 1988; 413:333-339.","journal-title":"Virchows Arch [A]"},{"key":"9671_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1210\/jcem-62-5-1011","volume":"62","author":"SL Asa","year":"1986","unstructured":"Asa SL, Gerrie BM, Singer W, Horvath E, Kovacs K, Smyth HS. Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas. J Clin Endocrinol Metab 1986; 62:1011-1019.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9671_CR14","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M. Clinical and Pathological Aspects of Silent Pituitary Adenomas. J Clin Endocrinol Metab 2019; 104(7):2473-2489.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9671_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12022-014-9347-2","volume":"26","author":"JA Balogun","year":"2015","unstructured":"Balogun JA, Monsalves E, Juraschka K et al. Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr Pathol 2015; 26(1):63-70.","journal-title":"Endocr Pathol"},{"issue":"5","key":"9671_CR16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11102-019-00981-9","volume":"22","author":"JP Almeida","year":"2019","unstructured":"Almeida JP, Stephens CC, Eschbacher JM et al. Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers. Pituitary 2019; 22(5):514-519.","journal-title":"Pituitary"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09671-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-021-09671-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-021-09671-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T15:19:21Z","timestamp":1629213561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-021-09671-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["9671"],"URL":"https:\/\/doi.org\/10.1007\/s12022-021-09671-4","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"16 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}